Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""VECURONIUM bromide"" wg kryterium: Temat


Tytuł:
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
Autorzy:
Kondo M; Department of Pharmacy, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Yoshida N; Department of Pharmacy, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Yoshida M; Department of Pharmacy, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Tanaka C; Department of Emergency and Critical Care Medicine, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Tagami T; Department of Emergency and Critical Care Medicine, Nippon Medical School Musashi Kosuigi Hospital, Kanagawa, Japan.
Horikawa K; Department of Pharmacy, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Sugaya K; Department of Pharmacy, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Takase H; Department of Pharmacy, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2023 Jan 01; Vol. 80 (1), pp. e53-e58.
Typ publikacji:
Journal Article
MeSH Terms:
Analgesics, Opioid*
Dexmedetomidine*
Humans ; Drug Incompatibility ; Remifentanil ; Sodium Chloride ; Anti-Bacterial Agents ; Infusions, Intravenous ; Hypnotics and Sedatives ; Midazolam ; Vecuronium Bromide ; Rocuronium ; Fentanyl ; Muscles
Czasopismo naukowe
Tytuł:
Comparison of intubation condition and the quality of muscle relaxation between rocuronium and vecuronium using "timing principle".
Autorzy:
Čaušević S; Department of Anaesthesiology and Intensive Care Unit, Cantonal Hospital Zenica, Bosnia and Herzegovina.
Rizvanović N; Department of Anaesthesiology and Intensive Care Unit, Cantonal Hospital Zenica, Bosnia and Herzegovina.
Pojskić B; Department of Internal Diseases, Cantonal Hospital Zenica, Bosnia and Herzegovina.
Pokaż więcej
Źródło:
Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina [Med Glas (Zenica)] 2020 Feb 01; Vol. 17 (1), pp. 7-14.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Neuromuscular Nondepolarizing Agents*
Vecuronium Bromide*
Androstanols ; Humans ; Intubation, Intratracheal ; Muscle Relaxation ; Rocuronium ; Time Factors
Czasopismo naukowe
Tytuł:
Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
Autorzy:
Voss T; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Wang A; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
DeAngelis M; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Speek M; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Saldien V; Department of Anesthesiology, Antwerp University Hospital, Edegem and University of Antwerp, Antwerp, Belgium.
Hammer GB; Departments of Pediatrics and Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA.
Wrishko R; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Herring WJ; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Pokaż więcej
Źródło:
Paediatric anaesthesia [Paediatr Anaesth] 2022 Mar; Vol. 32 (3), pp. 436-445. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji:
Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial
MeSH Terms:
Anaphylaxis*/chemically induced
Anesthetics*/adverse effects
Neuromuscular Blockade*/methods
Neuromuscular Nondepolarizing Agents*/adverse effects
Bradycardia/chemically induced ; Child ; Humans ; Neostigmine ; Rocuronium ; Sugammadex/adverse effects ; Vecuronium Bromide/adverse effects
Czasopismo naukowe
Tytuł:
Required dose of sugammadex or neostigmine for reversal of vecuronium-induced shallow residual neuromuscular block at a train-of-four ratio of 0.3.
Autorzy:
He J; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
He H; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
Li X; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
Sun M; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
Lai Z; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
Xu B; Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2022 Jan; Vol. 15 (1), pp. 234-243. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Dose-Response Relationship, Drug*
Delayed Emergence from Anesthesia/*chemically induced
Delayed Emergence from Anesthesia/*drug therapy
Neostigmine/*administration & dosage
Neostigmine/*pharmacology
Sugammadex/*administration & dosage
Sugammadex/*pharmacology
Vecuronium Bromide/*pharmacology
Humans
Czasopismo naukowe
Tytuł:
A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants.
Autorzy:
Herring WJ; Department of Clinical Research, Merck & Co., Inc., Kenilworth, NJ, USA. .
Mukai Y; Department of Clinical Research, Merck & Co., Inc., Kenilworth, NJ, USA.
Wang A; Department of Clinical Research, Merck & Co., Inc., Kenilworth, NJ, USA.
Lutkiewicz J; Department of Clinical Research, Merck & Co., Inc., Kenilworth, NJ, USA.
Lombard JF; Department of Clinical Research, Merck & Co., Inc., Kenilworth, NJ, USA.
Lin L; Department of Clinical Research, Merck & Co., Inc., Kenilworth, NJ, USA.
Watkins M; Department of Clinical Research, Merck & Co., Inc., Kenilworth, NJ, USA.
Broussard DM; Ochsner Clinic Foundation, New Orleans, LA, USA.
Blobner M; Department of Anesthesiology and Intensive Care Medicine, School of Medicine, Technical University of Munich, Munich, Germany.; Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ulm, Ulm, Germany.
Pokaż więcej
Źródło:
BMC anesthesiology [BMC Anesthesiol] 2021 Oct 28; Vol. 21 (1), pp. 259. Date of Electronic Publication: 2021 Oct 28.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Neuromuscular Blockade*
Bradycardia/*chemically induced
Sugammadex/*adverse effects
Tachycardia/*chemically induced
Aged ; Cholinergic Agents/administration & dosage ; Cholinergic Agents/adverse effects ; Double-Blind Method ; Female ; Glycopyrrolate/administration & dosage ; Glycopyrrolate/adverse effects ; Humans ; Male ; Neostigmine/administration & dosage ; Neostigmine/adverse effects ; Neuromuscular Nondepolarizing Agents/administration & dosage ; Rocuronium/administration & dosage ; Rocuronium/adverse effects ; Sugammadex/administration & dosage ; Vecuronium Bromide/administration & dosage ; Vecuronium Bromide/adverse effects
Czasopismo naukowe
Tytuł:
Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery.
Autorzy:
Mostoller K; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Wrishko R; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Maganti L; Department of Biostatistics, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Herring WJ; Department of Clinical Research, Merck & Co., Inc., Kenilworth, New Jersey, USA.
van Zutphen-van Geffen M; Certara Strategic Consulting, Oss, The Netherlands.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2021 Mar; Vol. 14 (2), pp. 737-744. Date of Electronic Publication: 2020 Dec 16.
Typ publikacji:
Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Neuromuscular Blockade/*adverse effects
Neuromuscular Nondepolarizing Agents/*antagonists & inhibitors
Obesity, Morbid/*surgery
Sugammadex/*pharmacokinetics
Adult ; Body Mass Index ; Dose-Response Relationship, Drug ; Drug Dosage Calculations ; Female ; Humans ; Ideal Body Weight ; Male ; Middle Aged ; Models, Biological ; Neuromuscular Blockade/methods ; Neuromuscular Nondepolarizing Agents/administration & dosage ; Obesity, Morbid/metabolism ; Rocuronium/administration & dosage ; Rocuronium/antagonists & inhibitors ; Sugammadex/administration & dosage ; Vecuronium Bromide/administration & dosage ; Vecuronium Bromide/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
The effects of intravenous anesthetics on QT interval during anesthetic induction with sevoflurane.
Autorzy:
Terao Y; Department of Anesthesia, Nagasaki Rosai Hospital, 2-12-5 Setogoe, Sasebo, 857-0134, Japan. .
Higashijima U; Department of Anesthesia, Nagasaki Rosai Hospital, 2-12-5 Setogoe, Sasebo, 857-0134, Japan.
Toyoda T; Department of Anesthesia, Nagasaki Rosai Hospital, 2-12-5 Setogoe, Sasebo, 857-0134, Japan.
Ichinomiya T; Department of Anesthesia, Nagasaki Rosai Hospital, 2-12-5 Setogoe, Sasebo, 857-0134, Japan.
Fukusaki M; Department of Anesthesia, Nagasaki Rosai Hospital, 2-12-5 Setogoe, Sasebo, 857-0134, Japan.
Hara T; Department of Anesthesiology, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
Pokaż więcej
Źródło:
Journal of anesthesia [J Anesth] 2016 Dec; Vol. 30 (6), pp. 929-934. Date of Electronic Publication: 2016 Sep 21.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Anesthetics, Intravenous/*administration & dosage
Methyl Ethers/*administration & dosage
Propofol/*administration & dosage
Vecuronium Bromide/*administration & dosage
Adult ; Aged ; Anesthetics, Intravenous/pharmacology ; Arterial Pressure/drug effects ; Electrocardiography/drug effects ; Female ; Fentanyl/administration & dosage ; Heart Rate/drug effects ; Humans ; Intubation, Intratracheal ; Male ; Middle Aged ; Sevoflurane ; Vecuronium Bromide/pharmacology
Czasopismo naukowe
Tytuł:
Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
Autorzy:
Horrow JC; Department of Clinical Research, Merck & Co., Inc., 2000 Galloping Hill Rd, UG-4C-13, Kenilworth, NJ, 07033, USA.; Present address: Anesthesiology & Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Li W; Department of Clinical Research, Merck & Co., Inc., 2000 Galloping Hill Rd, UG-4C-13, Kenilworth, NJ, 07033, USA.
Blobner M; Department of Anaesthesiology and Intensive Care Medicine, School of Medicine, Technical University of Munich, Munich, Germany.; Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ulm, Munich, Germany.
Lombard J; Department of Clinical Research, Merck & Co., Inc., 2000 Galloping Hill Rd, UG-4C-13, Kenilworth, NJ, 07033, USA.
Speek M; Department of Clinical Research, Merck & Co., Inc., 2000 Galloping Hill Rd, UG-4C-13, Kenilworth, NJ, 07033, USA.
DeAngelis M; Department of Clinical Research, Merck & Co., Inc., 2000 Galloping Hill Rd, UG-4C-13, Kenilworth, NJ, 07033, USA.
Herring WJ; Department of Clinical Research, Merck & Co., Inc., 2000 Galloping Hill Rd, UG-4C-13, Kenilworth, NJ, 07033, USA. william_.
Pokaż więcej
Źródło:
BMC anesthesiology [BMC Anesthesiol] 2021 Feb 27; Vol. 21 (1), pp. 62. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Anesthesia Recovery Period*
Body Weight/*physiology
Neuromuscular Blockade/*methods
Obesity, Morbid/*physiopathology
Rocuronium/*pharmacology
Sugammadex/*administration & dosage
Vecuronium Bromide/*pharmacology
Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Ideal Body Weight/physiology ; Male ; Middle Aged ; Neuromuscular Nondepolarizing Agents/pharmacology ; Time Factors
Czasopismo naukowe
Tytuł:
Nasogastric Tube Insertion in Intubated Patients: Comparison of Three Different Positions; Standard Sniffing Position, Additional Flexion of the Neck, and Standard Sniffing Position with Lateral Neck Pressure .
Autorzy:
Mohanan, Shyam
Gupta, Madhu
Dabas, Manisha
Pokaż więcej
Temat:
GASTRIC intubation
ENDOTRACHEAL tubes
ANESTHESIA
OXYMETAZOLINE
VECURONIUM bromide
Źródło:
Turkish Journal of Anaesthesiology & Reanimation; Aug2023, Vol. 51 Issue 4, p318-323, 6p
Czasopismo naukowe
Tytuł:
Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
Autorzy:
de Boer HD; Department of Anesthesiology and Pain Medicine, Martini General Hospital Groningen, Groningen, the Netherlands. .
Carlos RV; Department of Anesthesiology, Child Institute, Hospital das Clinicas, Sao Paulo University Medical School, Sao Paulo, Brazil.
Brull SJ; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.
Pokaż więcej
Źródło:
BMC anesthesiology [BMC Anesthesiol] 2018 Nov 06; Vol. 18 (1), pp. 159. Date of Electronic Publication: 2018 Nov 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neuromuscular Monitoring/*methods
Neuromuscular Nondepolarizing Agents/*antagonists & inhibitors
Sugammadex/*administration & dosage
Cost Savings ; Dose-Response Relationship, Drug ; Humans ; Neostigmine/administration & dosage ; Neostigmine/economics ; Neuromuscular Blockade/methods ; Neuromuscular Nondepolarizing Agents/administration & dosage ; Rocuronium/administration & dosage ; Rocuronium/antagonists & inhibitors ; Sugammadex/economics ; Vecuronium Bromide/administration & dosage ; Vecuronium Bromide/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
The pharmacodynamics of vecuronium in chronic renal failure patients: the impact of different priming doses.
Autorzy:
Tarbeeh GA; Department of Anesthesia and Surgical ICU, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Othman MM
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2012; Vol. 34 (7), pp. 827-33. Date of Electronic Publication: 2012 May 18.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Kidney Failure, Chronic/*metabolism
Neuromuscular Nondepolarizing Agents/*administration & dosage
Vecuronium Bromide/*administration & dosage
Adult ; Female ; Humans ; Male ; Neuromuscular Nondepolarizing Agents/pharmacokinetics ; Preoperative Period ; Prospective Studies ; Vecuronium Bromide/pharmacokinetics
Czasopismo naukowe
Tytuł:
Monitoring of vecuronium-induced neuromuscular block at the sternocleidomastoid muscle in anesthetized patients.
Autorzy:
Saitoh Y; Department of Anesthesiology, Tsujinaka Hospital Kashiwanoha, 148-6 Kashiwanoha Campus, 178-2 Wakashiba, Kashiwa, Chiba 277-0871, Japan. />Oshima T
Nakata Y
Pokaż więcej
Źródło:
Journal of anesthesia [J Anesth] 2010 Dec; Vol. 24 (6), pp. 838-44. Date of Electronic Publication: 2010 Aug 20.
Typ publikacji:
Journal Article; Retracted Publication
MeSH Terms:
Anesthesia*
Neuromuscular Blockade*
Neuromuscular Nondepolarizing Agents*
Vecuronium Bromide*
Aged ; Colon/surgery ; Digestive System Surgical Procedures ; Electric Stimulation ; Female ; Humans ; Male ; Monitoring, Intraoperative ; Muscle, Skeletal ; Myography ; Sample Size
Czasopismo naukowe
Tytuł:
Priming with rocuronium or vecuronium prevents remifentanil-mediated muscle rigidity and difficult ventilation.
Autorzy:
Nakada J; Department of Anesthesiology, Aichi Cancer Center, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan.
Nishira M
Hosoda R
Funaki K
Takahashi S
Matsura T
Inagaki Y
Pokaż więcej
Źródło:
Journal of anesthesia [J Anesth] 2009; Vol. 23 (3), pp. 323-8. Date of Electronic Publication: 2009 Aug 14.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Androstanols*
Neuromuscular Nondepolarizing Agents*
Respiration, Artificial*
Vecuronium Bromide*
Anesthesia, Intravenous/*adverse effects
Anesthetics, Intravenous/*adverse effects
Muscle Rigidity/*chemically induced
Muscle Rigidity/*prevention & control
Piperidines/*adverse effects
Aged ; Female ; Humans ; Laryngeal Masks ; Male ; Middle Aged ; Oxygen/blood ; Remifentanil ; Rocuronium
Czasopismo naukowe
Tytuł:
Monitoring of vecuronium-induced neuromuscular blockade during one-lung ventilation.
Autorzy:
Saitoh Y; Department of Anesthesiology, Satte General Hospital, 4-14-24 Higashi, Satte, Saitama, 340-0114, Japan.
Oshima T
Nakata Y
Pokaż więcej
Źródło:
Journal of anesthesia [J Anesth] 2008; Vol. 22 (4), pp. 378-84. Date of Electronic Publication: 2008 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Neuromuscular Blockade*
Neuromuscular Nondepolarizing Agents*
Vecuronium Bromide*
Lung/*surgery
Respiration, Artificial/*methods
Adult ; Anesthesia ; Anesthesia, General ; Colon/surgery ; Electromyography ; Female ; Humans ; Male ; Middle Aged ; Monitoring, Intraoperative
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies